Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
出版年份 2023 全文链接
标题
Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection
作者
关键词
-
出版物
Frontiers in Surgery
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-01-06
DOI
10.3389/fsurg.2022.1002075
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine
- (2022) Liru Li et al. BMC CANCER
- Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab–paclitaxel or FOLFIRINOX: A post–hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)
- (2022) Taro Shibuki et al. BMC CANCER
- The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study
- (2022) Yilin Yu et al. Translational Oncology
- The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
- (2022) Li Chen et al. Frontiers in Pharmacology
- Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma
- (2022) Xuanhong He et al. Frontiers in Surgery
- Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial
- (2021) Ashley M. Hopkins et al. Cancers
- Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma
- (2021) Ji-Feng Feng et al. Cancer Management and Research
- The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy
- (2021) Koki Obayashi et al. International Journal of Clinical Oncology
- Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy
- (2021) Lingling Li et al. Frontiers in Oncology
- Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer
- (2020) Shuai-Shuai Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
- (2020) Kei Sonehara et al. Thoracic Cancer
- Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials
- (2020) Carmen Criscitiello et al. ONCOLOGIST
- Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
- (2020) Yizhi Wang et al. Frontiers in Oncology
- Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer
- (2020) Wenxian Wang et al. Frontiers in Oncology
- Inflammation and Cancer: Triggers, Mechanisms, and Consequences
- (2019) Florian R. Greten et al. IMMUNITY
- Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer
- (2019) Dickran Kazandjian et al. JAMA Oncology
- A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma
- (2018) Yi Wang et al. Journal of Cancer
- Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
- (2018) Carlos Rosales Frontiers in Physiology
- Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Laura Mezquita et al. JAMA Oncology
- The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review
- (2018) Ross D. Dolan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer
- (2018) Stijn van Roessel et al. JAMA Surgery
- Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
- (2018) Yangbo Feng et al. Cancer Medicine
- Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy
- (2017) Shu-Lin Yu et al. Scientific Reports
- Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
- (2016) P. F. Ferrucci et al. ANNALS OF ONCOLOGY
- Derived neutrophil/lymphocyte ratio predicts gemcitabine therapy outcome in unresectable pancreatic cancer
- (2016) REI SUZUKI et al. Oncology Letters
- Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies
- (2015) Fausto Petrelli et al. ACTA ONCOLOGICA
- Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
- (2015) David A. Quigley et al. Molecular Oncology
- Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
- (2014) Faruk Tas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
- (2014) Peng Xue et al. Cancer Medicine
- Elevated Preoperative Neutrophil-to-lymphocyte Ratio as a Predictor of Survival After Gastroenterostomy in Patients with Advanced Pancreatic Adenocarcinoma
- (2013) Teiichi Sugiura et al. ANNALS OF SURGICAL ONCOLOGY
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- (2013) M Stotz et al. BRITISH JOURNAL OF CANCER
- Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy
- (2013) Michael Haas et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Improvement of surgical results for pancreatic cancer
- (2013) Werner Hartwig et al. LANCET ONCOLOGY
- External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
- (2013) Joanna Szkandera et al. PLoS One
- Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
- (2012) De-shen Wang et al. MEDICAL ONCOLOGY
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
- (2011) G. Garcea et al. WORLD JOURNAL OF SURGERY
- Modelling prognostic factors in advanced pancreatic cancer
- (2008) D D Stocken et al. BRITISH JOURNAL OF CANCER
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now